A comparison study between combination of 50% trichloroacetic acid (TCA) and intralesional meglumine antimoniate (MA) versus intralesional meglumine antimoniate (MA) alone in the treated of cutaneous leishmaniasis

Authors

  • jamal khadam Tishreen University

Abstract

Background: Cutaneous leishmaniasis is a parasitic disease. It is considered an endemic disease in Syria and causes an important health problem due to the defective scars, which leave in the absence of treatment.

Objective: This study was conducted to compare the efficacy of 50% trichloroacetic acid (TCA) and intralesional meglumine antimoniate (MA) versus intralesional meglumine antimoniate (MA) in patients of cutaneous leishmaniasis (CL).

Methods: It was an analytical study, conducted in department of Dermatology and Venerology, Tishreen University Hospital, Lattakia, between September 2020 to December 2021. A total of 50 patients were taken in this study. Group I (25 patients) received 50% TCA locally once a week for 6 weeks with intralesional injection meglumine antimoniate till blanching once a week for 6 weeks, and group II (25 patients) was treated with intralesional injection meglumine antimoniate alone.

Results: Efficacy was observed in patients 23 (92%) of group I and in 19 patients (76%) of group II (P-value =0.028).

Conclusion: The study showed that combination therapy with TCA 50% locally and intralesional MA gave better results in comparison to the patients treated with intralesional MA alone.

Downloads

Published

2022-09-06

How to Cite

1.
خدام ج. A comparison study between combination of 50% trichloroacetic acid (TCA) and intralesional meglumine antimoniate (MA) versus intralesional meglumine antimoniate (MA) alone in the treated of cutaneous leishmaniasis. Tuj-hlth [Internet]. 2022Sep.6 [cited 2024Apr.27];44(4):25-31. Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/12974

Issue

Vol. 44 No. 4 (2022): Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)

1 2 > >>